Buy Rating Backed by Potential Regulatory Tailwinds for Arcellx's CAR-T Therapy
TipRanksApr 12 13:35
Needham: Reiterates Arcellx (ACLX.US) rating and adjusted from buy to buy rating, target price is $81.00.
Zhitong FinanceApr 11 18:20
Arcellx Analyst Ratings
BenzingaApr 11 18:12
Optimizing Investment Decisions: Unveiling the Buy Rating for Arcellx Inc.
TipRanksApr 11 17:56
Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX) and Adaptive Biotechnologies (ADPT)
TipRanksApr 4 19:10
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arcellx Inc (ACLX) and AdaptHealth (AHCO)
TipRanksMar 18 19:10
Arcellx Analyst Ratings
BenzingaMar 18 19:07
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Arcellx Inc (ACLX) and Exact Sciences (EXAS)
TipRanksMar 15 13:42
Arcellx Analyst Ratings
BenzingaMar 15 00:38
Analysts Are Bullish on Top Healthcare Stocks: Silk Road Medical (SILK), Arcellx Inc (ACLX)
TipRanksMar 14 20:40
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Ionis Pharmaceuticals (IONS) and Arcellx Inc (ACLX)
TipRanksMar 14 17:50
Arcellx Analyst Ratings
BenzingaMar 7 16:54
Arcellx Analyst Ratings
BenzingaMar 5 23:16
Truist Securities Maintains Buy on Arcellx, Raises Price Target to $87
BenzingaMar 5 23:17
HC Wainwright & Co. Maintains Buy on Arcellx, Raises Price Target to $82
BenzingaMar 1 04:28
Arcellx Analyst Ratings
BenzingaMar 1 04:25
Barclays Adjusts Arcellx's Price Target to $73 From $62, Keeps Overweight Rating
MT NewswiresMar 1 01:26
Buy Rating Affirmed for Arcellx Inc's Anito-cel Amid Superior Safety Profile and Strong Market Entry Prospects
TipRanksFeb 29 23:05
Baird Maintains Outperform on Arcellx, Raises Price Target to $77
BenzingaFeb 29 20:14
Anticipating Arcellx Inc. Catalysts: Strong CAR-T Trial Data Underpin Buy Rating
TipRanksFeb 29 19:25
No Data
No Data